理邦仪器：国际市场保持双位数增长，预计扣非后归母净利润同比大增90%—120%

Core Viewpoint - The company, Lifesense Instruments (300206), forecasts a significant increase in net profit for 2025, with expectations of a year-on-year growth of 75% to 105% [2] Financial Performance - The company anticipates a net profit attributable to shareholders of 284 million to 332 million yuan, representing a year-on-year increase of 75% to 105% [2] - The expected net profit after deducting non-recurring items is projected to be between 273 million and 316 million yuan, indicating a substantial year-on-year growth of 90% to 120% [2] Business Strategy - The company is steadily advancing its overseas manufacturing strategy, contributing to overall revenue growth [2] - The international market is experiencing double-digit growth, particularly in patient monitoring and ultrasound imaging segments [2] Operational Efficiency - The company is focusing on enhancing management efficiency and refining operations, leading to effective reductions in both marketing and R&D expenses [2]